Clinicopathologic factors affecting discrepancies in HER2 overexpression between core needle biopsy and surgical biopsy in breast cancer patients according to neoadjuvant treatment or not

Background: Accurate determination of human epidermal growth factor receptor 2 (HER2) status on breast core needle biopsy (CNB) tissue is important for determining neoadjuvant chemotherapies (NACs) for primary breast cancer. However, HER2 discrepancies occur before and after surgery, creating diffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Young-Hoon, Hong, Soon Auck, Ahn, Hye Shin, Ahn, Soo kyung, Kim, Min Kyoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210558/
https://www.ncbi.nlm.nih.gov/pubmed/34149935
http://dx.doi.org/10.7150/jca.59419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210558/
https://www.ncbi.nlm.nih.gov/pubmed/34149935
http://dx.doi.org/10.7150/jca.59419

Ejemplares similares